central nervous system disease: A disease involving the central nervous system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
428 |
4. Check minimum number of eventsNone |
428 |
5. Include endpointsNone |
428 |
6. Filter based on genotype QC (FinnGen only) |
428 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G90-G99
- Name in latin
- Aliae morbositates systematis nervosi centralis
Similar endpoints
↥List of similar endpoints to
Other disorders of central nervous system
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3599 | 1799 | 1755 |
| Only index persons | 2683 | 1459 | 1224 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 51.05 | 50.08 | 51.69 |
| Only index persons | 46.73 | 46.94 | 46.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 428 | 259 | 169 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.07 |
| Median age at first event (years) | 48.08 | 45.14 | 52.58 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 381
- Matched controls
- 3807
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
+∞
200.2
174
*
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
+∞
96.0
88
*
3499X
ICD-9 Finland
Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system
+∞
75.6
70
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.4
43.4
96
131
AA1AD
NOMESCO Finland
CT of head and brain
5.3
39.7
148
410
G96.8
ICD-10 Finland
Other specified disorders of central nervous system
+∞
36.0
34
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
8.6
33.5
77
109
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
60.0
32.9
38
7
TAB00
NOMESCO Finland
Lumbar puncture
9.1
27.2
59
75
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
290.3
27.1
27
*
R51.80
ICD-10 Finland
Headache
4.4
24.9
101
286
G96.1
ICD-10 Finland
Disorders of meninges, not elsewhere classified
+∞
21.0
20
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
110.8
19.8
21
*
M03BX01
ATC
baclofen; systemic
14.3
19.6
33
25
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
15.1
19.4
32
23
N03AX12
ATC
gabapentin; oral
3.9
18.9
87
270
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.6
18.1
37
42
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
22.2
17.5
25
12
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.8
16.4
57
135
N03AX16
ATC
pregabalin; oral
2.9
15.7
115
497
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.1
15.3
50
110
ZXD05
NOMESCO Finland
Urgent procedure
2.6
15.3
151
776
ZXC95
NOMESCO Finland
Use of surgical navigator
17.4
14.9
23
14
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.1
14.7
61
171
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
14.7
14
*
R1250
NOMESCO Finland
Evaluation of functional capability
9.7
14.5
29
32
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
28.4
14.4
19
7
XA800
NOMESCO Finland
Neuropsychological investigation
6.0
14.4
40
73
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.6
14.1
42
83
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
24.9
13.9
19
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
13.6
107
476
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
13.6
90
359
AAK10
NOMESCO Finland
Repair of dura
+∞
13.6
13
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
13.1
65
212
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
12.6
12
*
N03AF02
ATC
oxcarbazepine; oral
7.1
12.5
30
45
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
12.4
56
169
XCK00
NOMESCO Finland
Perimetry
4.7
12.3
42
97
G82.2
ICD-10 Finland
Paraplegia, unspecified
38.9
12.3
15
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.4
12.2
32
54
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.8
12.2
24
26
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.3
12.1
37
76
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
12.0
68
244
S18
ICPC
Laceration/cut
2.2
11.8
170
1019
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
11.7
166
988
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
11.5
11
*
N03AX14
ATC
levetiracetam; systemic
7.5
11.2
26
37
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
25.9
11.2
15
6
N03AE01
ATC
clonazepam; systemic
4.6
11.0
38
89
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
10.9
126
677
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
61.7
10.7
12
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
10.5
42
114
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
112.9
10.5
11
*
ZZC00
NOMESCO Finland
Graft of fascia
+∞
10.5
10
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
10.4
166
1024
R20.2
ICD-10 Finland
Paraesthesia of skin
4.3
10.3
38
96
H02AB09
ATC
hydrocortisone; systemic
6.8
10.2
25
39
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
10.1
78
339
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
15.1
10.1
16
11
UDM02
NOMESCO Finland
Sinoscopy
7.7
9.8
22
30
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
13.8
9.7
16
12
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.8
9.7
16
12
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
9.7
87
410
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
9.7
151
917
L89
ICD-10 Finland
Decubitus ulcer and pressure area
11.8
9.6
17
15
Z3226
NOMESCO Finland
Physiotherapist
2.4
9.5
86
406
XKC03
NOMESCO Finland
Water cystometry
6.0
9.4
25
44
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.0
9.3
22
33
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.0
9.3
22
33
Z2446
NOMESCO Finland
Social worker
3.6
9.3
41
122
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
16.1
9.1
14
9
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
9.0
51
182
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
19.1
9.0
13
7
WX882
NOMESCO Finland
High dependency care
5.6
8.9
25
47
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
8.9
44
143
R4110
NOMESCO Finland
Physiotherapy
2.2
8.9
108
587
109
Kela drug reimbursment
Multiple sclerosis
11.1
8.9
16
15
G35
ICD-10 Finland
Multiple sclerosis
7.9
8.7
19
25
G03.9
ICD-10 Finland
Meningitis, unspecified
51.1
8.7
10
*
A28
ICPC
Limited function/disability NOS
2.7
8.5
60
247
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
13.1
8.4
14
11
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
8.4
8
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
8.4
8
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
8.3
87
437
ZZF00
NOMESCO Finland
Graft of adipose tissue
14.9
8.3
13
9
Z3231
NOMESCO Finland
Registered nurse
2.1
8.2
115
657
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
8.2
63
269
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.8
8.2
34
96
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
22.6
8.1
11
5
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.7
8.0
34
98
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.0
8.0
17
22
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
7.9
26
59
R4130
NOMESCO Finland
Speech therapy
9.7
7.8
15
16
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.6
7.8
26
60
R11
ICD-10 Finland
Nausea and vomiting
3.4
7.8
36
112
H47.2
ICD-10 Finland
Optic atrophy
45.9
7.7
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
7.7
58
247
AA1AA
NOMESCO Finland
Head X-ray examination
25.6
7.6
10
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
25.6
7.6
10
*
R50.9
ICD-10 Finland
Fever, unspecified
2.4
7.5
67
311
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.0
7.3
19
33
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
7.3
7
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
7.3
7
*
H02AB06
ATC
prednisolone; systemic
1.8
7.3
176
1218
L28
ICPC
Limited function/disability (L)
2.4
7.3
64
297
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
16.1
7.3
11
7
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.2
7.2
37
124
J01EA01
ATC
trimethoprim; systemic
2.0
7.2
102
583
N18
ICPC
Paralysis/weakness
8.2
7.2
15
19
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.5
7.2
24
56
R01AD08
ATC
fluticasone; nasal
2.0
7.1
114
683
R42
ICD-10 Finland
Dizziness and giddiness
2.1
7.0
81
425
N02BE01
ATC
paracetamol; systemic, rectal
2.0
7.0
313
2644
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
6.9
56
247
R55
ICD-10 Finland
Syncope and collapse
2.7
6.8
46
182
ZXA05
NOMESCO Finland
Left side
2.0
6.8
95
538
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
6.8
28
80
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
6.7
36
125
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.5
6.7
30
91
L03AX13
ATC
glatiramer acetate; parenteral
23.0
6.7
9
*
N06AB04
ATC
citalopram; systemic
2.1
6.7
84
458
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.0
6.6
20
42
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
6.6
48
199
R53
ICD-10 Finland
Malaise and fatigue
2.1
6.6
83
451
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
5.5
6.5
18
34
J01DA01
ATC
[U] cefalexin; systemic
1.8
6.5
239
1863
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.8
6.5
20
43
CS494
NOMESCO Finland
Other visual field testing
7.6
6.5
14
19
ZX120
NOMESCO Finland
Intravenous
2.7
6.4
44
176
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
14.6
6.4
10
7
T90.5
ICD-10 Finland
Sequelae of intracranial injury
14.6
6.4
10
7
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
14.6
6.4
10
7
N02AA05
ATC
oxycodone; systemic
2.4
6.4
56
259
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
6.4
94
541
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
6.3
62
302
N04BB01
ATC
amantadine; oral
9.5
6.3
12
13
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
18.4
6.3
9
5
L03AB07
ATC
interferon beta-1a; parenteral
18.4
6.3
9
5
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
6.3
88
497
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
+∞
6.3
6
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
6.3
6
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
+∞
6.3
6
*
G00.1
ICD-10 Finland
Pneumococcal meningitis
+∞
6.3
6
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
6.3
6
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
6.3
6
*
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
6.3
6
*
J01DB01
ATC
cefalexin; oral
1.9
6.2
307
2612
H53.2
ICD-10 Finland
Diplopia
5.9
6.2
16
28
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
6.2
71
371
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.0
6.1
18
37
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
6.1
32
110
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
12.8
6.1
10
8
N30.9
ICD-10 Finland
Cystitis, unspecified
3.4
6.1
28
88
ZXE00
NOMESCO Finland
One hour or less
1.7
6.0
150
1034
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
6.0
60
294
N06AA09
ATC
amitriptyline; systemic
2.5
6.0
48
211
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044290) Cell count panel - Cerebral spinal fluid
71
61
13.76
71.44
1.5
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
74
68
12.95
71.40
1.6
1.4
mmol/l
3.6
3.6
0.07
69
62
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
48
22
24.45
65.81
1.7
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
70
67
12.30
65.62
1.7
1.4
e6/l
378.7
6.7
1.39
62
55
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
70
67
12.30
65.62
1.7
1.4
e6/l
5753.4
259.4
0.88
62
56
(3016018) Differential panel - Cerebral spinal fluid
44
22
22.18
58.09
1.5
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
32
12
28.74
46.85
1.5
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
219
1174
2.77
23.72
7.0
7.7
inr
1.2
1.2
0.18
55
352
(3023410) Appearance of Cerebral spinal fluid
29
34
9.08
23.03
1.8
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
114
441
3.16
22.43
1.9
2.3
s
28.8
29.6
1.16
109
425
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
23
11.00
21.97
1.1
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
91
312
3.43
21.78
6.8
8.7
kpa
14.5
12.2
2.73
86
299
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
91
312
3.43
21.78
6.8
8.7
kpa
5.2
5.2
0.01
86
297
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
255
1530
2.65
21.25
8.3
6.5
mmol/l
1.2
1.2
1.04
226
1293
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
238
1387
2.61
20.98
8.7
6.1
mmol/l
1.2
1.2
1.40
223
1262
(3003396) Base excess in Arterial blood by calculation
88
314
3.27
19.62
7.0
8.8
mmol/l
0.5
1.4
0.86
69
252
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
152
749
2.60
18.52
2.7
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
284
1872
2.54
18.27
6.8
4.6
mmol/l
6.5
6.6
0.51
272
1734
(3044640) Blood type and Crossmatch panel - Blood
186
1015
2.47
18.16
3.3
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
95
377
2.95
17.51
2.5
1.6
—
—
—
0
0
(4027681)
20
21
9.94
17.12
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
155
803
2.46
16.68
6.2
4.1
—
—
—
0
0
(3026782) Osmolality of Urine
130
623
2.56
16.51
3.6
2.7
mosm/kgh2o
530.5
562.0
0.93
118
529
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
24
8.69
15.50
2.5
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
74
275
3.04
15.20
7.2
9.5
%
96.2
95.2
0.64
69
266
(3005719) IgG [Mass/volume] in Serum or Plasma
69
248
3.12
15.00
3.6
2.3
g/l
9.8
10.3
0.46
62
230
(3030467) Casts [#/volume] in Urine by Automated count
163
900
2.31
14.86
4.8
3.0
e6/l
0.2
0.3
1.46
130
668
(3002173) Hemoglobin [Mass/volume] in Arterial blood
70
257
3.06
14.66
7.0
9.9
g/l
121.4
122.8
0.23
65
250
(3014576) Chloride [Moles/volume] in Serum or Plasma
86
357
2.76
14.39
6.3
6.7
mmol/l
105.5
104.0
1.85
86
352
(3026008) Bacteria identified in Urine by Culture
164
920
2.27
14.28
4.5
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
23
36
6.69
14.24
1.0
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
90
385
2.69
14.20
5.6
6.1
mmol/l
1.0
1.1
1.37
83
356
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
234
1517
2.20
14.19
5.2
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
186
1106
2.21
13.97
8.9
5.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
161
903
2.26
13.97
2.6
2.1
u/l
144.5
298.5
1.15
155
851
(36304419) Bacteria [Presence] in Urine
159
888
2.26
13.93
4.6
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
129
660
2.37
13.89
3.3
2.7
e6/l
4.1
6.8
1.33
118
590
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
14
11.07
13.82
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
17
9.74
13.51
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
100
461
2.53
13.49
2.5
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
102
477
2.49
13.34
2.9
4.1
mmol/l
0.8
0.8
0.28
97
456
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
20
8.81
13.33
1.1
1.1
u/l
1.2
1.0
—
10
12
(3002582) Erythrocytes [#/volume] in Urine
169
990
2.17
12.96
4.8
3.1
e6/l
23.6
109.2
0.70
137
754
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
248
1683
2.13
12.92
6.1
6.2
umol/l
10.2
11.1
0.48
237
1597
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
188
1157
2.11
12.61
4.7
3.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
254
1765
2.08
12.11
9.4
6.1
e9/l
0.2
0.2
0.82
237
1565
(3006315) Basophils [#/volume] in Blood
247
1701
2.07
12.04
8.8
5.7
e9/l
0.0
0.0
2.50
229
1485
(3001604) Monocytes [#/volume] in Blood
246
1697
2.06
11.88
8.8
5.7
e9/l
0.6
0.6
0.99
228
1475
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
99
483
2.37
11.66
2.1
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
63
248
2.81
11.55
7.0
8.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
21
7.88
11.49
3.4
2.4
%
11.7
9.0
0.29
11
12
(3018095) Leukocytes [#/volume] in Urine
186
1173
2.04
11.38
5.6
3.7
e6/l
62.2
93.9
0.43
145
816
(3019198) Lymphocytes [#/volume] in Blood
249
1747
2.02
11.22
9.1
5.8
e9/l
1.9
2.0
0.85
236
1565
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
56
210
2.92
11.21
9.3
8.3
mmol/l
24.7
24.9
0.12
56
210
(3014111) Lactate [Moles/volume] in Serum or Plasma
64
260
2.72
11.03
5.6
6.9
mmol/l
1.1
1.2
0.90
64
248
(3035637) Corticotropin [Mass/volume] in Plasma
22
44
5.22
10.63
2.5
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
204
1356
1.96
10.51
4.8
4.5
g/l
35.3
36.2
1.25
194
1272
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
133
3.30
10.48
6.3
14.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
270
1983
1.98
10.28
11.6
9.1
e9/l
4.3
4.0
1.26
248
1734
(3019069) Monocytes/100 leukocytes in Blood
229
1606
1.92
9.84
9.3
6.1
%
8.6
8.5
0.20
220
1507
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
22
7.03
9.79
3.5
2.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
222
1553
1.89
9.50
9.3
5.9
%
0.7
0.7
0.35
213
1453
(3006504) Eosinophils/100 leukocytes in Blood
226
1594
1.89
9.39
9.1
5.9
%
3.0
2.8
0.62
216
1489
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
14
8.79
9.39
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
296
2283
1.96
9.30
5.9
4.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
31
5.67
9.04
3.5
2.2
e9/l
1.4
1.1
0.33
12
14
(3002030) Lymphocytes/100 leukocytes in Blood
231
1658
1.85
8.92
9.5
5.9
%
27.4
28.6
0.96
223
1558
(3018010) Neutrophils/100 leukocytes in Blood
229
1641
1.85
8.87
8.9
5.7
%
57.7
56.9
0.46
221
1544
(3008152) Bicarbonate [Moles/volume] in Arterial blood
45
174
2.77
8.49
10.9
9.5
mmol/l
25.7
24.6
1.18
38
164
(3019060) Gas panel - Arterial blood
45
174
2.77
8.49
6.8
6.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1159
1.83
8.14
3.8
3.5
ng/l
26.8
38.6
0.70
118
739
(40758558) Short blood count panel - Blood
139
873
1.88
8.02
8.4
6.5
—
—
—
0
0
(3012544) pH of Venous blood
63
295
2.33
8.00
5.4
4.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
331
2.25
7.88
2.1
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
69
338
2.24
7.88
2.1
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
32
5.16
7.72
2.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
82
3.45
7.65
1.8
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
61
287
2.31
7.65
5.5
4.5
mmol/l
1.6
1.8
0.14
52
226
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
62
302
2.23
7.16
3.9
3.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
143
938
1.79
7.01
4.7
3.7
ph
7.4
7.4
0.20
28
174
(3019309) Folate [Moles/volume] in Red Blood Cells
91
517
1.97
7.00
1.7
1.6
nmol/l
1174.4
1204.8
0.10
77
398
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
31
4.98
6.98
1.5
1.4
g/l
0.3
0.4
—
10
21
(4062490)
15
32
4.82
6.74
1.5
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
50
228
2.35
6.73
1.9
2.1
g/l
68.4
67.4
0.66
45
210
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
64
324
2.15
6.71
2.4
4.1
u/l
232.0
250.0
0.59
54
306
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
309
2537
1.78
6.61
9.2
7.1
u/l
80.1
78.7
0.20
297
2376
(3021589) Normoblasts [#/volume] in Blood
208
1540
1.68
6.47
13.3
9.0
e9/l
0.0
0.0
0.22
181
1257
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
163
2.53
6.33
1.9
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
158
2.54
6.23
6.0
5.2
mmol/l
23.7
23.8
0.06
33
142
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
94
564
1.85
6.07
4.5
2.5
e6/l
1.7
1.0
0.71
51
320
(3023183) Ammonium ion [Moles/volume] in Plasma
20
59
3.51
5.93
2.4
4.3
umol/l
34.9
36.7
0.14
14
53
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
386
3452
2.20
5.75
23.6
12.5
mg/l
19.8
22.2
1.10
350
2642
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
72
403
1.95
5.73
3.3
2.3
%
20.6
23.1
0.83
65
351
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
118
771
1.73
5.69
2.0
1.8
mg/l
0.8
1.2
1.53
92
594
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
212
2.25
5.62
7.8
5.4
mmol/l
2.4
1.9
0.49
34
161
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
21
5.35
5.55
1.8
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
52
3.57
5.51
1.6
1.6
g/l
0.5
0.7
0.53
13
40
(4035726)
54
279
2.07
5.36
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
18
5.66
5.34
2.7
3.3
u/ml
639.1
670.0
—
10
18
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
87
529
1.81
5.34
4.7
2.7
e6/l
2.4
2.6
0.12
43
285
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
5
0
+∞
5.22
2.6
0.0
%
7.0
—
—
5
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
5
0
+∞
5.22
3.4
0.0
%
49.0
—
—
5
0
(3022948) Iron [Moles/volume] in Serum or Plasma
79
474
1.82
5.06
3.2
2.3
umol/l
12.1
13.6
0.92
74
440
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
792
1.66
4.86
3.0
2.1
mg/l
3.1
3.1
0.13
98
680
(40768804) Tissue Pathology biopsy report
182
1371
1.57
4.86
2.2
2.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
7
11.61
4.80
2.0
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
207
2.14
4.71
2.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
58
3.20
4.69
2.9
4.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
43
3.58
4.65
1.2
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
137
974
1.60
4.65
2.8
2.6
u/l
51.0
55.8
1.29
127
902
(3013707) Erythrocyte sedimentation rate by Westergren method
296
2504
1.59
4.63
5.1
4.0
mm/h
12.2
11.1
0.66
279
2312
(3047181) Lactate [Moles/volume] in Blood
22
81
2.81
4.59
6.8
12.1
mmol/l
1.1
1.3
0.90
17
68
(3027315) Oxygen [Partial pressure] in Blood
20
70
2.95
4.55
2.7
3.7
kpa
8.7
8.8
0.17
20
70
(3013290) Carbon dioxide [Partial pressure] in Blood
20
70
2.95
4.55
2.7
3.7
kpa
5.3
5.0
0.98
20
70
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
44
3.50
4.50
1.2
1.5
nmol/l
0.5
0.5
0.14
15
39
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
306
2618
1.59
4.47
5.2
3.9
pmol/l
14.7
14.6
0.52
285
2412
(3021601) Nitrite [Presence] in Urine by Test strip
207
1632
1.52
4.36
6.2
4.7
estimate
0.0
0.0
0.00
51
304
(3023520) Reticulocytes [#/volume] in Blood
45
236
2.01
4.30
2.2
2.7
e9/l
79.8
72.8
0.65
27
178
(3027945) Reticulocytes/100 erythrocytes in Blood
58
332
1.86
4.30
2.7
2.7
%
1.8
1.8
0.11
50
305
(3020891) Body temperature
27
115
2.44
4.25
6.8
4.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
208
1649
1.51
4.22
4.5
3.5
estimate
0.0
0.0
0.50
51
293
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
62
2.99
4.22
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
205
1623
1.50
4.17
4.6
3.4
estimate
0.0
0.0
0.00
51
303
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
64
2.89
4.00
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
64
2.89
4.00
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
172
2.13
3.98
7.7
5.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
102
701
1.60
3.91
1.6
1.5
nmol/l
19.3
21.5
0.64
87
601
(3004588) Protein electrophoresis panel - Serum or Plasma
36
182
2.07
3.81
2.0
1.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
26
115
2.34
3.79
2.4
2.0
ug/l
0.7
3.5
0.60
17
104
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
55
2.98
3.77
3.4
3.9
e9/l
3.5
4.3
0.91
16
55
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
5
12.14
3.77
1.3
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
97
2.45
3.72
1.2
1.8
g/l
2.9
3.1
0.51
15
81
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
177
2.06
3.71
1.5
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
12
6.77
3.69
2.5
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
105
2.36
3.59
1.2
1.8
g/l
3.4
3.8
0.74
15
80
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
105
2.36
3.59
1.2
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
105
2.36
3.59
1.2
1.8
g/l
6.6
7.5
1.88
16
83
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1344
1.47
3.59
2.8
2.3
nmol/l
74.4
75.2
0.17
152
1218
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
349
3137
1.61
3.59
5.9
4.6
mu/l
1.7
2.2
0.83
326
2883
(3000494) Fungus identified in Specimen by Culture
67
423
1.69
3.57
1.7
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
57
2.88
3.56
3.4
4.3
%
55.6
57.1
0.15
16
57
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
6
10.12
3.50
1.2
8.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
148
1128
1.48
3.49
3.4
3.3
u/l
28.8
31.2
0.63
139
1079
(3019225) pH of Specimen
46
263
1.84
3.44
5.2
3.6
—
—
—
0
0
(3015736) pH of Urine
164
1281
1.45
3.39
4.0
3.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
89
2.43
3.37
2.1
2.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
29
143
2.10
3.29
1.2
1.3
u/ml
0.2
3.1
—
6
9
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
54
2.84
3.28
3.3
4.8
—
1137.4
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
7
8.67
3.27
1.2
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
7
8.67
3.27
1.2
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
112
817
1.50
3.24
1.3
1.3
u/ml
0.9
1.8
0.72
26
218
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
38
3.22
3.23
1.2
1.5
nmol/l
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
389
3620
1.82
3.22
21.3
11.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
11
6.45
3.19
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
61
2.69
3.17
2.7
2.9
%
17.3
16.2
—
7
29
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
67
2.60
3.16
2.2
2.2
g/l
135.8
129.2
—
10
48
(3011397) Hemoglobin [Presence] in Urine by Test strip
106
770
1.50
3.12
4.1
3.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
99
2.29
3.11
1.2
1.8
g/l
11.2
10.5
0.27
16
88
(3026389) Candida sp identified in Specimen by Organism specific culture
12
39
3.14
3.11
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
119
2.17
3.11
2.0
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
139
1067
1.45
3.10
2.9
3.2
mmol/l
2.4
2.4
0.07
122
950
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
28
140
2.07
3.08
5.0
3.8
%
55.4
49.5
0.55
28
140
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
155
1216
1.43
3.06
2.2
1.8
pmol/l
95.9
96.0
0.01
78
623
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
12
5.91
3.03
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
12
5.91
3.03
1.1
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
15
57
2.69
2.99
1.1
1.5
u/l
33.7
27.8
0.32
15
46
(3037522) Nuclear Ab [Titer] in Serum
71
478
1.58
2.94
1.3
1.4
titre
1093.3
466.3
—
9
111
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
22
4.16
2.89
1.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
40
234
1.78
2.80
1.2
1.2
u/ml
101.0
149.1
0.64
35
215
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
32
3.18
2.66
3.5
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
41
246
1.74
2.65
3.3
4.3
%
0.0
0.2
0.66
12
65
(3001019) Free T4 and TSH panel - Serum or Plasma
9
225
0.39
2.64
1.4
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
405
0.49
2.63
1.1
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
74
2.35
2.61
3.8
3.6
u/ml
0.3
0.3
—
8
45
(3010838) Calcium [Moles/time] in 24 hour Urine
7
15
4.72
2.60
1.6
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
109
824
1.43
2.59
2.4
3.1
ng/l
1201.1
1269.8
0.05
88
695
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
86
622
1.48
2.57
1.7
1.7
pmol/l
460.4
436.3
0.35
77
528
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
11
5.51
2.55
1.2
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
45
2.71
2.47
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
182
1511
1.36
2.45
3.8
2.7
ug/l
122.5
103.1
0.53
166
1412
(3013512) EKG study
115
887
1.41
2.43
4.2
3.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
12
5.05
2.41
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
84
2.19
2.38
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
8
6.31
2.38
1.0
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
17
4.17
2.37
1.6
1.6
u/l
8.9
13.8
—
7
17
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
21
105
2.05
2.35
1.8
1.8
—
192.0
—
0
5
(3021440) Promyelocytes/100 leukocytes in Blood
41
257
1.66
2.28
3.3
4.3
%
0.0
0.1
2.18
13
75
(40761536) Microorganisms panel - Urine sediment
43
273
1.64
2.28
5.9
3.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
16
73
2.24
2.24
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
94
2.07
2.19
3.1
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
260
2301
1.33
2.18
4.0
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
116
1.95
2.15
1.8
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
62
436
1.49
2.13
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
104
807
1.38
2.10
5.8
4.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
109
854
1.37
2.07
5.1
3.8
estimate
0.0
0.0
0.69
52
299
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
39
248
1.63
2.07
2.9
3.3
mmol/l
1.2
1.2
0.01
34
217
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
364
1.52
2.03
4.6
3.9
%
31.9
31.5
0.09
40
239
(3002179) Metamyelocytes/100 leukocytes in Blood
38
243
1.62
1.98
3.3
4.2
%
0.5
0.4
—
10
58
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
21
3.37
1.97
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
76
565
1.42
1.96
3.6
3.2
ng/l
52.8
303.2
1.96
54
412
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
384
1.50
1.96
2.7
3.1
umol/l
9.2
7.0
0.33
47
331
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
26
150
1.78
1.95
3.0
2.9
%
1.3
1.3
0.05
26
150
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
260
2321
1.31
1.95
4.2
3.1
u/l
63.8
43.3
1.74
244
2199
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
78
2.09
1.93
1.4
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
59
420
1.47
1.92
1.5
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
341
3169
1.37
1.90
19.5
11.5
ml/min/173m2
86.5
84.5
0.88
302
2588
(3017181) Myelocytes/100 leukocytes in Blood
42
279
1.56
1.88
3.4
4.1
%
0.5
0.9
0.93
12
90
(3051611) Lipemic interference index of Serum or Plasma
8
28
2.89
1.87
4.1
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
95
741
1.36
1.85
1.8
1.4
g/l
2.2
2.4
0.31
64
453
(3041096) Erythrocytes [Presence] in Urine by Automated
113
906
1.34
1.84
4.3
3.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.20
1.83
1.2
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
385
3662
1.51
1.81
14.0
9.6
u/l
26.5
25.8
0.46
376
3539
(3000093) Morphology [Interpretation] in Blood Narrative
7
23
3.08
1.80
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
13
61
2.17
1.73
1.2
1.5
nmol/l
0.2
0.3
—
7
45
(44813793)
7
24
2.95
1.73
1.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
13
3.88
1.72
1.0
2.9
ug/l
97.2
134.0
—
5
13
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
104
1.87
1.70
2.5
3.3
%
103.1
91.0
1.19
19
96
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
31
2.61
1.66
6.0
1.4
ug/l
17.3
24.0
—
8
31
(3024928) Oxygen saturation in Venous blood
12
56
2.18
1.62
2.1
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
149
1263
1.28
1.59
4.7
3.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
26
2.72
1.58
2.3
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
20
3.03
1.58
3.0
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
107
1296
0.77
1.58
3.2
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
308
1.48
1.57
2.6
2.4
u/l
25.5
33.9
1.80
37
256
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
15
3.36
1.52
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
15
3.36
1.52
1.4
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
51
2.19
1.52
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
21
2.88
1.51
1.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
21
2.88
1.51
1.2
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
13
65
2.03
1.50
4.6
3.2
mmol/l
8.5
7.4
0.40
13
65
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
140
1.68
1.48
4.6
1.9
u/l
1381.7
2876.3
—
5
48
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
59
2.06
1.45
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
16
3.15
1.44
7.0
6.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
22
2.75
1.44
2.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
56
419
1.39
1.42
1.9
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
40
2.28
1.41
1.0
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
53
2.10
1.39
1.3
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
82
1.86
1.37
1.3
1.4
ug/g
320.8
316.9
—
8
48
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
91
741
1.29
1.32
1.8
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
103
854
1.27
1.29
3.2
3.2
mg/l
1469.6
216.2
0.66
63
555
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
326
3067
1.26
1.27
5.9
5.3
mmol/mol
39.8
39.3
0.31
303
2873
(3024731) MCV [Entitic volume]
399
3862
1.49
1.27
33.6
18.5
fl
90.9
90.7
0.51
399
3818
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
344
3258
1.28
1.26
4.1
4.2
mmol/l
5.8
5.9
0.25
322
3008
(3035941) MCH [Entitic mass]
399
3863
1.49
1.25
33.6
18.4
pg
30.2
30.2
0.20
399
3818
(3035285) Chloride [Moles/volume] in Venous blood
9
45
2.02
1.24
3.0
2.8
mmol/l
103.1
105.8
—
9
45
(3041354) Potassium [Moles/volume] in Venous blood
9
45
2.02
1.24
3.0
2.8
mmol/l
3.8
4.0
—
9
45
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
101
1.71
1.21
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
71
1.86
1.20
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
114
965
1.25
1.20
3.6
3.1
mmol/l
7.3
8.0
0.63
94
818
(3000963) Hemoglobin [Mass/volume] in Blood
399
3867
1.47
1.20
33.9
18.6
g/l
132.8
135.6
3.80
399
3820
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
185
0.53
1.18
1.9
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
102
1.69
1.18
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
57
1.95
1.18
6.5
3.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
57
1.95
1.18
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
20
2.52
1.15
1.0
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
20
2.52
1.15
1.0
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
103
1.68
1.14
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
258
2381
1.21
1.14
3.8
3.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
30
2.35
1.13
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
88
1.73
1.12
1.1
1.1
—
3.8
—
0
12
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
73
1.81
1.12
1.2
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
270
1.41
1.11
1.2
1.2
iu/ml
62.7
180.2
2.49
13
114
(42529406) Shigella sp [Presence] in Stool by Culture
17
104
1.66
1.11
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
97
817
1.24
1.07
2.6
2.6
umol/l
354.2
8758.7
4.47
75
711
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
10
52
1.95
1.07
1.4
1.4
ug/l
2.2
3.4
—
5
45
(3050129) First trimester maternal screen panel - Serum or Plasma
6
124
0.48
1.06
1.2
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
902
1.23
1.06
3.9
4.0
mg/mmol
5.0
9.5
0.85
61
564
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
106
1.63
1.04
1.5
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
76
1.73
1.00
2.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
382
1.32
0.99
9.9
6.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
61
1.82
0.99
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
36
1.96
0.97
1.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
36
1.96
0.97
1.3
1.9
pg
28.0
32.1
—
7
36
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
50
1.82
0.97
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
357
1.32
0.97
14.2
22.2
inr
1.0
1.3
—
6
49
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
70
575
1.26
0.96
3.2
2.8
mmol/l
2.4
2.4
0.14
59
504
(4010399)
33
243
1.39
0.96
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
77
1.71
0.96
1.1
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.4
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
27
2.24
0.94
2.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
86
1.65
0.92
3.3
3.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
79
1.67
0.89
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
195
1.41
0.88
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
44
1.83
0.86
3.3
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
104
1.56
0.85
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
47
1.72
0.81
1.8
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
269
1.33
0.80
1.6
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
82
1.60
0.79
1.9
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
101
882
1.19
0.78
1.5
1.7
mmol/l
1.5
1.4
0.54
87
754
(3048689) Calprotectin [Mass/mass] in Stool
53
433
1.26
0.78
2.4
2.4
ug/g
105.7
118.0
0.17
40
339
(3000330) Specific gravity of Urine by Test strip
22
157
1.42
0.78
3.5
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
100
0.49
0.78
1.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
54
1.68
0.75
1.7
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
253
0.70
0.74
1.2
1.4
—
—
—
0
0
(44790048)
7
38
1.86
0.74
1.7
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
38
1.86
0.74
1.1
1.5
—
—
—
0
0
(44790049)
7
38
1.86
0.74
1.7
1.3
—
—
—
0
0
(44806118)
7
38
1.86
0.74
1.7
1.3
—
—
—
0
0
(44790047)
7
38
1.86
0.74
1.7
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
40
1.76
0.71
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
363
0.76
0.71
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
41
1.72
0.70
2.0
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
71
610
1.20
0.67
1.3
1.3
iu/ml
24.6
34.0
0.26
17
205
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
180
1.35
0.66
2.9
2.8
e6/l
0.1
0.1
0.20
24
173
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
2.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
2.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
2.0
1.5
g/l
1.4
1.0
—
5
28
(3049717) Cytology report of Urine Cyto stain
14
95
1.49
0.65
3.5
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
679
1.18
0.64
2.1
1.9
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
20
0.00
0.60
0.0
5.3
—
39.4
—
0
5
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
52
1.55
0.59
2.1
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
72
1.54
0.59
1.5
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
22
0.00
0.59
0.0
1.5
—
38.9
—
0
16
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
53
1.52
0.58
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
417
0.80
0.58
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
35
1.72
0.58
3.0
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.8
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
36
294
1.25
0.56
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
107
1.42
0.56
4.9
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
65
1.55
0.56
1.2
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
37
1.63
0.55
3.0
3.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
186
1.31
0.55
1.5
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
249
1.26
0.55
3.8
3.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
1.3
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
66
1.53
0.53
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
126
1.36
0.52
1.5
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
295
3054
0.89
0.50
30.0
16.1
g/l
332.3
332.8
0.40
295
3035
(3044941) Cell count panel - Synovial fluid
7
46
1.53
0.48
1.6
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
68
602
1.15
0.47
1.3
1.3
u/ml
2.9
12.9
2.55
25
236
(3017732) Neutrophils [#/volume] in Blood
28
229
1.24
0.45
5.1
2.9
e9/l
4.1
4.2
0.03
22
191
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
195
0.76
0.42
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
8.1
—
0
15
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
79
1.40
0.41
1.6
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
198
1.22
0.37
1.6
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
108
1.31
0.35
2.1
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
43
1.40
0.35
2.5
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
44
1.37
0.34
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
44
1.37
0.34
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
133
0.75
0.34
1.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
45
1.34
0.34
1.3
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
103
959
1.10
0.33
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
447
1.13
0.32
2.6
1.8
%
1.6
1.4
0.94
44
405
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
128
1.26
0.32
5.1
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
52
1.35
0.31
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
138
1.24
0.31
1.8
1.7
—
—
—
0
0
(3000492) Spirometry study
39
344
1.15
0.31
1.9
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
354
1.14
0.30
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
250
1.17
0.30
1.7
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
213
1.18
0.29
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
92
859
1.09
0.28
4.3
4.7
ug/l
2.4
2.7
0.24
80
764
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
132
1.22
0.26
1.3
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
61
563
1.10
0.24
2.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
331
3254
1.08
0.23
25.5
13.4
%
38.7
40.1
1.93
240
2515
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
153
1.18
0.22
2.7
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
48
522
0.91
0.22
3.3
2.8
ug/l
0.9
0.8
0.27
34
337
(3045462) Protein/Creatinine [Ratio] in Urine
0
11
0.00
0.21
0.0
7.0
—
96.2
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
154
1.18
0.21
4.8
1.4
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
259
1.13
0.20
2.7
2.5
ml/min/173m2
74.6
67.4
0.51
16
108
(4034850)
14
117
1.20
0.20
13.9
10.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
80
1.26
0.20
7.1
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
627
1.08
0.20
1.4
1.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.0
—
95.4
—
0
8
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.0
—
131.7
—
0
14
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.0
—
113.5
—
0
8
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
127
1.19
0.20
1.3
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
51
1.18
0.19
1.3
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
384
0.90
0.19
1.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
118
1.19
0.19
1.9
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
164
0.85
0.18
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
730
1.07
0.17
4.1
3.5
kg/l
1.0
1.0
—
8
98
(1002224) Polysomnography panel
15
173
0.86
0.17
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
70
1.15
0.16
1.1
3.0
—
3.0
—
0
9
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
44
472
0.92
0.16
2.3
2.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
72
1.11
0.16
1.1
1.1
—
13.0
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
80
1.13
0.15
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
418
0.93
0.14
2.3
1.9
—
—
—
0
0
(4094501)
10
84
1.20
0.14
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
38
356
1.07
0.12
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
137
0.87
0.12
1.2
1.3
miu/ml
105.6
256.6
—
5
68
(3027008) Opiates [Presence] in Urine
18
162
1.12
0.12
4.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
162
1.12
0.12
4.8
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
124
1.13
0.11
2.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
163
1.11
0.11
4.8
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
125
1.12
0.10
1.1
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
135
0.89
0.10
1.7
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
48
1.04
0.09
1.0
3.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
54
1.11
0.09
1.5
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
308
0.94
0.08
2.9
4.5
ug/l
10.1
44.9
0.70
23
249
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
58
1.03
0.08
1.5
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
65
0.77
0.08
1.4
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
68
1.03
0.08
1.9
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
81
0.86
0.07
2.4
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
86
1.05
0.07
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
68
697
0.97
0.05
4.1
4.2
%
22.5
21.4
0.22
36
331
(3027944) Amphetamines [Presence] in Urine
17
161
1.06
0.03
5.1
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
341
3422
0.98
0.03
4.7
4.6
mmol/l
2.8
2.8
0.17
319
3177
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
127
0.94
0.01
1.5
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
334
3349
0.99
0.01
4.4
4.1
mmol/l
1.4
1.5
2.64
310
3115
(3022621) pH of Urine by Test strip
18
187
0.96
0.01
2.5
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
335
3356
0.99
0.00
4.4
4.2
mmol/l
4.7
4.7
0.44
314
3139
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
325
3249
1.00
0.00
4.0
3.7
mmol/l
1.4
1.3
1.20
302
3010
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
7.1
—
0
6
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.2
2.3
u/ml
2.6
81.9
—
5
47
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
3.8
—
0
6
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.7
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
78
0.90
0.00
1.4
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
16.4
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
4.0
—
0.6
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
6
69
0.87
0.00
1.0
1.1
u/ml
0.2
0.4
—
6
34
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
174.6
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
69
0.87
0.00
2.2
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
79
1.01
0.00
1.3
1.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
74.3
—
0
7
(3003888) Timothy IgE Ab [Units/volume] in Serum
7
75
0.93
0.00
1.0
1.1
u/ml
1.0
1.7
—
7
41
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
30.8
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
6
65
0.92
0.00
1.3
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_CNSOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CNSOTH | 2.546 [1.94, 3.33] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.811 |
During the follow-up period (1.1.1998 — 31.12.2019), 160 out of 1017 females with G6_CNSOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CNSOTH | 2.416 [1.86, 3.13] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.03 |
During the follow-up period (1.1.1998 — 31.12.2019), 195 out of 815 males with G6_CNSOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_CNSOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.256% | 0.513% |
| 5 | 1.547% | 2.716% |
| 10 | 3.976% | 7.605% |
| 15 | 7.418% | 14.388% |
| 20 | 12.607% | 23.066% |
Relationships between endpoints
↥Index endpoint: G6_CNSOTH – Other disorders of central nervous system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data